Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder
Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder
Recruiting · NCT06651177 · Registry updated 2026-08-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder | Chemically-Induced Disorders, Hemic and Lymphatic Diseases, Narcotic-Related Disorders, Neoplasms by Histologic Type, Opioid Use Disorder, follicular lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, opiate dependence, psychiatric disorder, substance-related disorder | Recruiting | Phase 2 | 2026-08-11 | NCT06651177 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Institute on Drug Abuse (NIDA) | 549 |
| T. John Winhusen, PhD | 2 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Gateway Community Services | Jacksonville | United States | 3 |
| Healthy Minds/Chestnut Ridge | Morgantown | United States | 1 |
| IBIS Behavioral Health | Tampa | United States | 1 |
| Marshall Health | Huntington | United States | 6 |
| Prisma Health | Greenville | United States | 24 |
| Ruth M. Rothstein CORE Center | Chicago | United States | 2 |
| The Gibson Center for Behavioral Change | Cape Girardeau | United States | 1 |
| University of Utah | Salt Lake City | United States | 72 |
| Vanderbilt University Medical Center | Nashville | United States | 427 |